Literature DB >> 22495319

Screening for cancer with molecular markers: progress comes with potential problems.

John A Baron1.   

Abstract

Recent research has raised hopes for impressively accurate screening for cancer with molecular biomarkers. These molecular markers will probably be more sensitive and specific than older screening modalities, as well as easier to use. In this Essay, I argue that these sensitive screening tests might be clinically valuable - but that they will present unique issues in implementation and interpretation. These issues are likely to affect the way clinicians conduct screening and the way that they make diagnoses in individuals who screen positive for cancer.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22495319      PMCID： PMC3843943          DOI： 10.1038/nrc3260

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


  43 in total

1.  Overdiagnosis: An underrecognized cause of confusion and harm in cancer screening.

Authors:  W C Black
Journal:  J Natl Cancer Inst       Date:  2000-08-16       Impact factor: 13.506

2.  Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.

Authors:  Joyce A O'Shaughnessy; Gary J Kelloff; Gary B Gordon; Andrew J Dannenberg; Waun Ki Hong; Carol J Fabian; Caroline C Sigman; Monica M Bertagnolli; Steven P Stratton; Stephen Lam; William G Nelson; Frank L Meyskens; David S Alberts; Michele Follen; Anil K Rustgi; Vali Papadimitrakopoulou; Peter T Scardino; Adi F Gazdar; Lee W Wattenberg; Michael B Sporn; Wael A Sakr; Scott M Lippman; Daniel D Von Hoff
Journal:  Clin Cancer Res       Date:  2002-02       Impact factor: 12.531

3.  Cancer without disease.

Authors:  Judah Folkman; Raghu Kalluri
Journal:  Nature       Date:  2004-02-26       Impact factor: 49.962

4.  Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer.

Authors:  Henning Usadel; Jan Brabender; Kathy D Danenberg; Carmen Jerónimo; Susan Harden; James Engles; Peter V Danenberg; Stephen Yang; David Sidransky
Journal:  Cancer Res       Date:  2002-01-15       Impact factor: 12.701

Review 5.  Challenges to cancer control by screening.

Authors:  Michael N Pollak; William D Foulkes
Journal:  Nat Rev Cancer       Date:  2003-04       Impact factor: 60.716

6.  Use of proteomic patterns in serum to identify ovarian cancer.

Authors:  Emanuel F Petricoin; Ali M Ardekani; Ben A Hitt; Peter J Levine; Vincent A Fusaro; Seth M Steinberg; Gordon B Mills; Charles Simone; David A Fishman; Elise C Kohn; Lance A Liotta
Journal:  Lancet       Date:  2002-02-16       Impact factor: 79.321

7.  Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma.

Authors:  K Kawakami; J Brabender; R V Lord; S Groshen; B D Greenwald; M J Krasna; J Yin; A S Fleisher; J M Abraham; D G Beer; D Sidransky; H T Huss; T R Demeester; C Eads; P W Laird; D H Ilson; D P Kelsen; D Harpole; M B Moore; K D Danenberg; P V Danenberg; S J Meltzer
Journal:  J Natl Cancer Inst       Date:  2000-11-15       Impact factor: 13.506

8.  Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice.

Authors:  Katharina Marten; Christoph Bremer; Khashayarsha Khazaie; Mansoureh Sameni; Bonnie Sloane; Ching-Hsuan Tung; Ralph Weissleder
Journal:  Gastroenterology       Date:  2002-02       Impact factor: 22.682

9.  Enthusiasm for cancer screening in the United States.

Authors:  Lisa M Schwartz; Steven Woloshin; Floyd J Fowler; H Gilbert Welch
Journal:  JAMA       Date:  2004-01-07       Impact factor: 56.272

10.  The influence of finasteride on the development of prostate cancer.

Authors:  Ian M Thompson; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Gary J Miller; Leslie G Ford; Michael M Lieber; R Duane Cespedes; James N Atkins; Scott M Lippman; Susie M Carlin; Anne Ryan; Connie M Szczepanek; John J Crowley; Charles A Coltman
Journal:  N Engl J Med       Date:  2003-06-24       Impact factor: 91.245
View more
  12 in total

1.  Establishment of a novel human medulloblastoma cell line characterized by highly aggressive stem-like cells.

Authors:  Patrícia Benites Gonçalves da Silva; Carolina Oliveira Rodini; Carolini Kaid; Adriana Miti Nakahata; Márcia Cristina Leite Pereira; Hamilton Matushita; Silvia Souza da Costa; Oswaldo Keith Okamoto
Journal:  Cytotechnology       Date:  2015-09-10       Impact factor: 2.058

2.  Salivary biomarkers for cancer diagnosis: a meta-analysis.

Authors:  Óscar Rapado-González; Cristina Martínez-Reglero; Ángel Salgado-Barreira; Bahi Takkouche; Rafael López-López; María Mercedes Suárez-Cunqueiro; Laura Muinelo-Romay
Journal:  Ann Med       Date:  2020-04-11       Impact factor: 4.709

Review 3.  Predictive biomarkers for Barrett's esophagus: so near and yet so far.

Authors:  M R Timmer; G Sun; E C Gorospe; C L Leggett; L Lutzke; K K Krishnadath; K K Wang
Journal:  Dis Esophagus       Date:  2013-01-14       Impact factor: 3.429

4.  Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancer.

Authors:  Michael L Pearl; Qiang Zhao; Jie Yang; Huan Dong; Shaun Tulley; Qiao Zhang; Marc Golightly; Stanley Zucker; Wen-Tien Chen
Journal:  Gynecol Oncol       Date:  2014-06-24       Impact factor: 5.482

5.  Biomarkers for Bone Tumors: Discovery from Genomics and Proteomics Studies and Their Challenges.

Authors:  Wan I Wan-Ibrahim; Vivek A Singh; Onn H Hashim; Puteri S Abdul-Rahman
Journal:  Mol Med       Date:  2015-11-13       Impact factor: 6.354

6.  Danish clinical quality databases - an important and untapped resource for clinical research.

Authors:  Henrik Toft Sørensen; Lars Pedersen; Jørgen Jørgensen; Vera Ehrenstein
Journal:  Clin Epidemiol       Date:  2016-10-25       Impact factor: 4.790

Review 7.  Barrett's oesophagus: Current controversies.

Authors:  Chidi Amadi; Piers Gatenby
Journal:  World J Gastroenterol       Date:  2017-07-28       Impact factor: 5.742

8.  Tumor stress-induced phosphoprotein1 (STIP1) as a prognostic biomarker in ovarian cancer.

Authors:  Angel Chao; Chyong-Huey Lai; Chia-Lung Tsai; Swei Hsueh; Chuen Hsueh; Chiao-Yun Lin; Hung-Hsueh Chou; Yu-Jr Lin; Hsi-Wen Chen; Ting-Chang Chang; Tzu-Hao Wang
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

9.  Genetic variations of MUC17 are associated with endometriosis development and related infertility.

Authors:  Ching-Wen Yang; Cherry Yin-Yi Chang; Ming-Tsung Lai; Hui-Wen Chang; Cheng-Chan Lu; Yi Chen; Chih-Mei Chen; Shan-Chih Lee; Pei-Wen Tsai; Su-Han Yang; Chih-Hung Lin; Jim Jinn-Chyuan Sheu; Fuu-Jen Tsai
Journal:  BMC Med Genet       Date:  2015-08-19       Impact factor: 2.103

10.  Immunogenic FEAT protein circulates in the bloodstream of cancer patients.

Authors:  Yan Li; Kyosuke Kobayashi; Marwa M Mona; Chikako Satomi; Shinji Okano; Hiroyuki Inoue; Kenzaburo Tani; Atsushi Takahashi
Journal:  J Transl Med       Date:  2016-09-22       Impact factor: 5.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.